A recent study demonstrated that despite an increase in VEGF after IL-6 treatment of temporal artery explants from GCA patients, there was no increase in myofibroblast proliferation or migration after IL-6 treatment [166]. This evidence concerns the gene VEGFA and temporal arteritis.